These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8132440

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.
    Bendtsen L, Jensen R, Olesen J.
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):285-90. PubMed ID: 8795600
    [Abstract] [Full Text] [Related]

  • 3. Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine.
    Shimodozono M, Kawahira K, Kamishita T, Ogata A, Tohgo S, Tanaka N.
    Int J Neurosci; 2002 Oct; 112(10):1173-81. PubMed ID: 12587520
    [Abstract] [Full Text] [Related]

  • 4. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.
    Zanardi R, Franchini L, Serretti A, Perez J, Smeraldi E.
    J Clin Psychiatry; 2000 Jan; 61(1):26-9. PubMed ID: 10695642
    [Abstract] [Full Text] [Related]

  • 5. The effects of psychomotor performance of fluvoxamine versus mianserin in depressed patients in general practice.
    Moon CA, Jesinger DK.
    Br J Clin Pract; 1991 Jan; 45(4):259-62. PubMed ID: 1810359
    [Abstract] [Full Text] [Related]

  • 6. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
    Daléry J, Aubin V.
    Encephale; 2001 Jan; 27(1):71-81. PubMed ID: 11294041
    [Abstract] [Full Text] [Related]

  • 7. Sertraline in chronic tension-type headache.
    Singh NN, Misra S.
    J Assoc Physicians India; 2002 Jul; 50():873-8. PubMed ID: 12126338
    [Abstract] [Full Text] [Related]

  • 8. Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study.
    Fogelholm R, Murros K.
    Headache; 1992 Nov; 32(10):509-13. PubMed ID: 1468911
    [Abstract] [Full Text] [Related]

  • 9. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    Kiev A, Feiger A.
    J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424
    [Abstract] [Full Text] [Related]

  • 10. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
    Ottevanger EA.
    Encephale; 1995 Apr; 21(4):317-21. PubMed ID: 7588171
    [Abstract] [Full Text] [Related]

  • 11. [Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache].
    Tarasova SV, Amelin AV, Skoromets AA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008 Apr; 108(6):43-6. PubMed ID: 18577934
    [Abstract] [Full Text] [Related]

  • 12. A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline.
    Nappi G, Sandrini G, Granella F, Ruiz L, Cerutti G, Facchinetti F, Blandini F, Manzoni GC.
    Headache; 1990 Jun; 30(7):439-44. PubMed ID: 2119355
    [Abstract] [Full Text] [Related]

  • 13. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP.
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: a preliminary study.
    Niitsu T, Fujisaki M, Shiina A, Yoshida T, Hasegawa T, Kanahara N, Hashimoto T, Shiraishi T, Fukami G, Nakazato M, Shirayama Y, Hashimoto K, Iyo M.
    J Clin Psychopharmacol; 2012 Oct; 32(5):593-601. PubMed ID: 22926591
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness.
    Perez A, Ashford JJ.
    Curr Med Res Opin; 1990 Oct; 12(4):234-41. PubMed ID: 2127561
    [Abstract] [Full Text] [Related]

  • 16. Headache and noradrenergic involvement: the effects of alpha 2-stimulants and alpha 2-antagonists.
    Denaro A, Martucci N, Ruggieri S, Manna V, Agnoli A.
    Acta Psychiatr Scand Suppl; 1985 Oct; 320():20-5. PubMed ID: 3901672
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
    Kasper S, Möller HJ, Montgomery SA, Zondag E.
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821
    [Abstract] [Full Text] [Related]

  • 18. Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study.
    Langemark M, Loldrup D, Bech P, Olesen J.
    Headache; 1990 Feb; 30(3):118-21. PubMed ID: 2182566
    [Abstract] [Full Text] [Related]

  • 19. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
    McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH.
    Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
    [Abstract] [Full Text] [Related]

  • 20. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME, Nierenberg AA, Vrijland P, van Oers HJ, Schutte AJ, Simmons JH.
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.